Introduction Multiple sclerosis is the most common human demyelinating disease of the central nervous system, and the most frequent cause of chronic neurological disability in young adults. Symptoms of the disease usually appear in the 20 ?40 age group, but the most common age of onset is between 31 and 33 years of age, a time when most are in their prime and beginning careers or starting families. Symptoms rarely present before the age of 15, and after the age …showed first 75 words of 7159 total…

…showed last 75 words of 7159 total…the added diagnostic tool of MRI has brightened the horizon for many sufferers. The treatments that are currently under development might one day in the near future even improve things further. The next set of studies might include the administration of neuroprotective agents or molecules that would facilitate axonal regrowth. Clinics in the future might be involved in the administration of growth factors that promote the proliferation and survival of oligodendrocytes, or even their transplantation.